Peer-Reviewed Journal Articles

  1. Strassman RJ, Letourneau P, Wessells NK: Elongation of axons in an agar matrix that does not support cell locomotion. Experimental Cell Research 818:482-487, 1973
  2. Strassman RJ, Wessells NK: Orientational preferences shown by microspikes of growing nerve cells in vitro. Tissue and Cell 5:412-417, 1973
  3. Strassman RJ, Galanter M: The Abhidharma: A cross-cultural application of meditation. International Journal of Social Psychiatry 26:283-290, 1980
  4. Risch SC, Janowsky DS, Lisansky EJ, Strassman RJ, Rausch JL, Gillin JC, Judd LL, Huey L: Dexamethasone effects on self-rated mood in depressed inpatients. American Journal of Psychiatry 141:147-148, 1984
  5. Strassman RJ: Adverse reactions to psychedelic drugs: A review of the literature. Journal of Nervous and Mental Disease 172:577-595, 1984
  6. Greer G, Strassman RJ: Information on "Ecstasy." (letter) American Journal of Psychiatry 142:1391, 1985
  7. Strassman R: Light, season, and affective disorders. Western Journal of Medicine 142:678, 1985
  8. Kennedy B, Strassman RJ, Ziegler M, Janowsky DS, Risch SC, Huey L, Gillin JC: Cardiovascular, catecholamine and psychological responses to TRH in four types of affective disorder patients. Hormone and Metabolic Research 19:164-167, 1987
  9. Strassman RJ, Peake GT, Qualls CR, Lisansky EJ: A model for the study of the acute effects of melatonin in man. Journal of Clinical Endocrinology and Metabolism 65:847-852, 1987
  10. Rosenthal M, Strassman RJ: Melatonin does not impair corticotropin response of isolated pituitary cells. Neuroendocrinology Letters 10:27-32, 1988
  11. Strassman RJ, Peake GT, Qualls CR, Lisansky EJ: Lack of an acute modulatory effect of melatonin on human nocturnal thyrotropin and cortisol secretion. Neuroendocrinology 48:387-393, 1988
  12. Strassman RJ, Appenzeller O, Lewy AJ, Qualls CR, Peake GT: Increase in plasma melatonin, beta-endorphin and cortisol after a high-altitude mountain run. Relationship to performance and lack of an effect of naltrexone. Journal of Clinical Endocrinology and Metabolism 69:540-545, 1989
  13. Lisansky EJ, Peake GT, Strassman RJ, Qualls CR, Meikle AW, Risch SC, Fava G, Zownir-Brazis M, Hochla P, Britton D: Augmented pituitary corticotropin response to a threshold dosage of human corticotropin-releasing hormone in depressives pre-treated with metyrapone. Archives of General Psychiatry 46:641-649, 1989
  14. Strassman RJ, Qualls CR, Lisansky EJ, Peake GT: Sleep deprivation reduces LH secretion independently of melatonin. Acta Endocrinologica (Scandinavica) 124:646-651, 1991
  15. Strassman RJ, Qualls CR, Lisansky EJ, Peake GT: Elevated rectal temperature produced by all night bright light is reversed by melatonin infusion in men. Journal of Applied Physiology 71:2178-2182, 1991
  16. Strassman RJ: Human hallucinogenic drug research in the United States: A present-day case history and a review of the process. Journal of Psychoactive Drugs 23:29-38, 1991
  17. Strassman RJ: Human hallucinogen interactions with drugs affecting serotonergic neurotransmission. Neuropsychopharmacology 7:241-243; 1992
  18. Lisansky EJ, Hauger R, Strassman RJ, Dorin R, Meikle AW, Brazis M, Qualls CR, Turkin A. Beta-endorphin response to a low dosage of human corticotropin releasing hormone during metyrapone administration in depression. Endocrine Research. 18:241-260, 1992.
  19. Strassman RJ, Qualls CR. Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic and cardiovascular effects. Archives of General Psychiatry. 51:85-97, 1994.
  20. Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R. Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Archives of General Psychiatry. 51:98-108, 1994.
  21. Strassman RJ. Hallucinogenic drugs in psychiatric research and treatment. Perspectives and prospects. Journal of Nervous and Mental Disease. 183:127-138, 1995.
  22. Strassman RJ. Human psychopharmacology of N,N-dimethyltryptamine. Behavioral Brain Research. 73:121-124, 1996.
  23. Grob C, McKenna D, Callaway J, Brito G, Neves E, Oberlaender G, Saide O, Labigalini E, Tacla C, Miranda C, Strassman R, Boone K. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. Journal of Nervous and Mental Disease. 184: 86-94, 1996
  24. Strassman RJ, Qualls C, Berg LM. Differential tolerance development to biological and subjective effects of four closely-spaced administrations of N,N-dimethyltryptamine in humans. Biological Psychiatry 39:784-795, 1996
  25. Strassman RJ. Endogenous ketamine-like compounds and the NDE: If so, so what? Journal of Near-Death Studies 16:27-42, 1997
  26. Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-Byrne PP. Psychedelic effects of ketamine in normal volunteers: Relationship to steady-state plasma concentrations. Anesthesiology 88:82-88, 1998
  27. Riba J, Rodriguez-Fornelis A, Strassman RJ, Barbanoj M J. Psychometric assessment of the Hallucinogen Rating Scale in two different populations of hallucinogen users. Drug and Alcohol Dependence 62:215-223, 2001
  28. Krupitsky EM, Burakov AM, Romanov TN, Grinenko AY, Strassman RJ. Ketamine-assisted psychotherapy (KPT) of heroin addiction: Immediate effects and six month follow-up. Heffter Review of Psychedelic Research 2:88-101, 2001
  29. Krupitsky EM, Burakov AM, Romanov TN, Dunaevksy I, Strassman RJ, Grinenko AY. Ketamine psychotherapy for heroin addiction: Immediate effects and two-year follow-up. Journal of Substance Abuse Treatment (in press)

Book Chapters

  1. Lisansky EJ, Strassman RJ, Janowsky DS, Risch SC: Drug-induced psychoses. In: Tupin J, Halbreich U, Pena J (eds) Transient Psychosis: Diagnosis, Management, Evaluation. New York: Bruner/Mazel, 1984, pp. 80-110
  2. Strassman RJ. Human hallucinogenic drug research: Regulatory, clinical and scientific issues. In: Lin G, Glennon RA (eds) Hallucinogens: An Update (NIDA Research Monograph 146), 1994, pp 92-123
  3. Strassman RJ. Human psychopharmacology of LSD, DMT and related compounds. In: Pletscher A (ed) 50 Years of LSD: State of the Art and Perspectives of Hallucinogens. London: Parthenon, 1994, pp. 145-174
  4. Strassman RJ. Biomedical research with psychedelics: Current models and future prospects. In: Forte R (ed) Entheogens and the Future of Religion. San Francisco: CSP; 1997, pp 153-164

Book Reviews

  1. Hofmann A: LSD, My Problem Child: Reflections on Sacred Drugs, Mysticism, and Science. Am J Psychiatry 141:1626-1628, 1984
  2. Leary T: Flashbacks: An Autobiography. Am J Psychiatry 141:1626-1628, 1984
  3. Bakalar J, Grinspoon L: Drug Control in a Free Society. JAMA 254:2974-2975, 1985
  4. Grinspoon L, Bakalar J (Eds): Psychedelic Reflections. Am J Psychiatry 143:249-250, 1986
  5. Dobkin de Rios M: Hallucinogens: Cross-Cultural Perspectives. Psychiatry 50:90-93, 1987
  6. Westermeyer J: A Clinical Guide of Alcohol and Drug Problems. J Clin Psychiatry 48:421, 1987
  7. Levy S, Blume S (Eds): Addictions in the Jewish Community. Am J Psychiatry 145:121-122, 1988
  8. Herrington R, Jacobson G, Benzer D (Eds): Alcohol and Drug Abuse Handbook. J Clin Psychiatry 49:123-124, 1988
  9. Milkman H, Sunderwirth S: Craving for Ecstasy: The Consciousness and Chemistry of Escape. JAMA 259:2614-2615, 1988
  10. Hendin H, Haas A, Singer P, Ellner M, Ulman R: Living High: Daily Marijuana Use Among Adults. Am J Psychiatry 145:1467-1468, 1988
  11. Fisher S, Raskin A, Uhlenhuth EH (Eds): Cocaine: Clinical and Biobehavioral Aspects. J Clin Psychiatry 49:328, 1988
  12. Jacobs MR, Fehr KOB (Eds): Drugs and Drug Abuse, 2nd edition. J Clin Psychiatry 49:375, 1988
  13. Levinthal CF: Messengers of Paradise: Opiates and the Brain. JAMA 260:3350-3351, 1988
  14. Halaris A: Chronobiology and Psychiatric Disorders. Am J Psychiatry 146:113-114, 1989
  15. Lee MA, Shlain B: Acid Dreams. Am J Psychiatry 146:395-396, 1989
  16. Stevens J: Storming Heaven. Am J Psychiatry 146:395-396, 1989
  17. Nace EP: The Treatment of Alcoholism. J Clin Psychiatry 50:74-75, 1989
  18. Frances RJ, Miller SI: Clinical Textbook of Addictive Disorders. J Clin Psychiatry 52:435, 1991
  19. Grinspoon L, Bakalar J: Marijuana: Forbidden Medicine. JAMA 270:2878-2879, 1993
  20. McKenna T: Food of the Gods. Network (The Scientific and Medical Network Newsletter) 53:58-59, 1994
  21. Stafford P: Psychedelics Encyclopedia, 3rd ed. Am J Addict 3:178-180, 1994
  22. Mancall PC: Deadly Medicine: Indians and Alcohol in Early America. JAMA 275:646-647, 1996
  23. Zimmer L, Morgan JP: Marijuana Myths, Marijuana facts: A Review of the Scientific Evidence. JAMA 279:632-633, 1998
  24. Grinspoon L, Bakalar JB: Marihuana: Forbidden Medicine (rev. ed.). JAMA279:963-964, 1998
  25. Devereuex P: The Long Trip. Network (The Medical and Scientific Network Newsletter) 69:63-64, 1999

Popular Articles

  1. Strassman RJ. Sitting for sessions: Dharma & DMT research. Tricycle. The Buddhist Review 6:81-88,1996
  2. Strassman RJ. Where to with psychedelic research? Asylum (A magazine for democratic psychiatry) 11:4-6, 1999

Interviews/Featured In

  1. Interview by Thomas Lyttle. "Medicine, Alchemy and DMT." Entheos. The Journal of Psychedelic Spirituality 1:79-85, Summer 2001
  2. Interview. The Fatboss May 2000:16-17
  3. Interview by Scotto and James Kent. The Resonance Project 4:27-34, Spring 1999
  4. Featured in: Porush D. Finding God in the three-pound universe. Omni 16: 60-7, October 1993
Learn about Rick Strassmans Research Foundation
+ -
buy the book